Brief introduction：First generics in Chinese market, deemed to have completed the Quality Consistency Evaluation; Indicated in adults and pediatric patients 6 months and older for the: 1. Management of mild to moderate pain and the management of moderate to severe pain as an adjunct to opioid analgesics; 2. Reduction of fever.
